Skip to main content

Turner's Syndrome News

Novo Nordisk Receives FDA Approval for Norditropin FlexPro for Growth Hormone Treatment

PRINCETON, N.J., March 3, 2010 /PRNewswire/ – Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved Norditropin FlexPro (somatropin [rDNA origin] injection), a...

Ask a question

To post your own question to our community, sign in or create an account.